Although systemic chemotherapy has been improved, peritoneal carcinomatosis remains a
factor of poor prognosis in patients with colorectal cancer. In order to achieve a higher drug …

Background Peritoneal carcinomatosis of colorectal adenocarcinoma (CRC) origin is
common and is the second‐most frequent cause of death in colorectal cancer. There is …

Abstract Background Approximately 20–30% of patients with pT4 colon cancer develop
metachronous peritoneal metastases (PM). Due to restricted accuracy of imaging modalities …

Simple Summary The peritoneum, a common metastatic site of colorectal cancer (CRC), has
a high incidence and poor prognosis that makes it difficult to diagnose early. Peritoneal …

Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC), often
combined with systemic therapy, can be offered to selected colorectal peritoneal metastases …

Peritoneum is one of the common sites of metastasis in advanced stage colorectal cancer
patients. Colorectal cancer patients with peritoneal metastases (PM) are traditionally …

Background Standard treatment for ovarian epithelial cancer (OEC) consists of cytoreductive
surgery (CRS) and a platinum–taxane chemotherapy combination. There is increasing …

Objective. The main objective of the study was to determine the effect of the presence of
mutation in the KRAS gene on the survival in patients with colorectal cancer (CRC) and …

Background Standard treatment for colorectal peritoneal carcinomatosis typically involves
cytoreductive surgery, hyperthermic intraperitoneal chemotherapy (HIPEC), and if possible …

Objectives: Describe the types of malignancies involving the peritoneum. Outline the
presentation of peritoneal metastasis. Summarize the treatment of peritoneal metastases …